Businesses historically underutilize research and development (R&D) tax credits, partially due to a lack of awareness and, in recent years, the federal amortization requirement. However, after the passage of the H.R.1 - One Big Beautiful Bill Act (OBBBA), it’s time to revisit your R&D tax credit strategy and take advantage of the bill’s monumental changes to the federal R&D tax credit.
Under the “Tax Cuts and Jobs Act of 2017” (TCJA), businesses were required to capitalize and amortize domestic R&D costs over a five-year period – or a 15-year period, for foreign R&D expenditures – for tax years beginning after Dec. 31, 2021. This change significantly impacted many small businesses and startups’ cash flow and financial projections.
The OBBBA removes the amortization requirement, reinstates the full expensing of R&D costs in the year they are incurred, and allows qualifying small businesses to apply immediate expensing retroactively to tax years beginning after Dec. 31, 2021.
These changes allow companies investing in R&D to make the most of the federal R&D tax credit.
How the OBBBA Elevates Your Bottom Line
If your business previously skipped the federal R&D tax credit, now is the time to reconsider.
Here's how the OBBBA strengthens R&D’s financial benefits:
Now is the time to start a conversation about your business’ R&D strategy with your tax team.
Get the Latest OBBBA Insights
Read Acena Consulting’s complete OBBBA analysis, written by the Head of R&D, Rae Smoltz, BSBA, BSENRE. (So nice, we linked it twice!)
Register for our free monthly webinar, next on Aug. 19th, 2025: “Cracking the (Tax) Code for R&D.”
Lastly, to keep up with Acena and get the latest updates on tax policy and industry-specific incentives, visit our Acena Events page and follow Acena on LinkedIn and X.
//
Edited by Laura Whittenburg, MSBME, Sr. Technical Writer at Acena Consulting. Photo courtesy of O Palsson on Flickr.